WT mice with NR2F6 depletion in tumor cells showed a 45.85 to 62.95% reduction in tumor growth, while those with systemic NR2F6 loss showed a 30.77% reduction (Fig. 7A). The gene discussed is NR2F6; the disease is neoplasm.